---
source: federal-register
document_id: "2025-24196"
title: "Determination That MYSOLINE (Primidone) Suspension, 250 Milligrams/5 Milliliters, Was Withdrawn From Sale for Reasons of Safety or Effectiveness"
agencies: ["Health and Human Services Department", "Food and Drug Administration"]
published: 2026-01-02
fetched: 2026-01-04
type: notice
url: https://www.federalregister.gov/documents/2026/01/02/2025-24196/determination-that-mysoline-primidone-suspension-250-milligrams5-milliliters-was-withdrawn-from-sale
---

## Abstract
The Food and Drug Administration (FDA, Agency, or we) has determined that MYSOLINE (primidone) suspension, 250 milligrams (mg)/5 milliliters (mL), was withdrawn from sale for reasons of safety or effectiveness. The Agency will not accept or approve abbreviated new drug applications (ANDAs) for primidone suspension, 250 mg/5 mL.

## Key Details
- **Type:** notice
- **Agencies:** Health and Human Services Department, Food and Drug Administration
- **Published:** 2026-01-02
- **Source:** [federal-register](https://www.federalregister.gov/documents/2026/01/02/2025-24196/determination-that-mysoline-primidone-suspension-250-milligrams5-milliliters-was-withdrawn-from-sale)
